FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293252737> ?p ?o ?g. }

• W4293252737 endingPage "149" @default.
• W4293252737 startingPage "137" @default.
• W4293252737 abstract "Aim: The aim of the present investigation entails the development and evaluation of topical nanoemulgel formulation of tazarotene for effective treatment of excision wounds Background: Tazarotene (TZR) is a retinoid derivative marketed for the treatment of acne and psoriasis and the recent investigations indicate its excellent wound healing potential. Despite having magnificent wound healing potential, it suffers from pharmacokinetic limitations of low aqueous solubility and local bioavailability. Conventional marketed formulations of TZR have been reported to cause significant skin irritation and redness after its topical application. Keeping this in view, present investigation was designed to develop nanoemulsion based gel with intention to resolve the above mentioned pharmacokinetic and pharmacodynamic issues. Objective: The goal of the study was to develop a stable and effective tazarotene-loaded nanoemulgel for treating excision wounds which can also overcome the issues associated with the native drug. Methods: Various oils, surfactants and co-surfactants were selected on the basis of their solubilisation potential for tazarotene. Pseudoternary phase plots were constructed to obtain stable nanoemulsion region for various proportions of oil, surfactant: co-surfactant (Smix) and water and determine optimized concentration ranges for robust formulation of tazarotene. Various characterization parameters were studied to investigate the optimized formulation having desired attributes of nanoemulsion. Reducing power assay and phamacodymanic studies were conducted to determine the wound healing potential of developed nanoemulgel. Results: TZR loaded nanoemulsion was successfully developed with nano-sized globules using tea tree oil with Tween 20 as surfactant and PEG 400 as co-surfactant. Prepared nanoemulsions were thermodynamically stable and were further gellified using Carbopol 940 as biodegradable gelling polymer. Prepared gels showed good spreadability, drug permeation and stability. In vivo investigations demonstrated that optimized formulation successfully masked the irritant nature of tazarotene. Moreover, the pharmacodynamic evaluation of developed nanoemulsion gel revealed its significant analgesic, anti-inflammatory properties in addition to its markable wound contraction as compared to control. Conclusion: The results demonstrated potential of developed nanoemulgel over marketed formulation to overcome the drawbacks like redness and erythema. It also showed significant healing efficacy over other" @default.
• W4293252737 created "2022-08-27" @default.
• W4293252737 creator A5004950702 @default.
• W4293252737 creator A5013250263 @default.
• W4293252737 creator A5019283465 @default.
• W4293252737 creator A5031223762 @default.
• W4293252737 creator A5056099998 @default.
• W4293252737 creator A5066937344 @default.
• W4293252737 date "2022-07-01" @default.
• W4293252737 modified "2023-10-16" @default.
• W4293252737 title "Development and Evaluation of Topical Nanoemulgel Formulation of Tazarotene for Effective Treatment of Excision Wounds" @default.
• W4293252737 cites W1971241015 @default.
• W4293252737 cites W1974008347 @default.
• W4293252737 cites W1994308967 @default.
• W4293252737 cites W2003848126 @default.
• W4293252737 cites W2007075171 @default.
• W4293252737 cites W2016711385 @default.
• W4293252737 cites W2024016078 @default.
• W4293252737 cites W2044244106 @default.
• W4293252737 cites W2048089967 @default.
• W4293252737 cites W2064146223 @default.
• W4293252737 cites W2064910281 @default.
• W4293252737 cites W2067673077 @default.
• W4293252737 cites W2074718848 @default.
• W4293252737 cites W2088204759 @default.
• W4293252737 cites W2092487497 @default.
• W4293252737 cites W2125266622 @default.
• W4293252737 cites W2158921004 @default.
• W4293252737 cites W2166547808 @default.
• W4293252737 cites W2184184250 @default.
• W4293252737 cites W2265120954 @default.
• W4293252737 cites W2323907717 @default.
• W4293252737 cites W2371460981 @default.
• W4293252737 cites W2417702853 @default.
• W4293252737 cites W2471222887 @default.
• W4293252737 cites W2506444115 @default.
• W4293252737 cites W2508091476 @default.
• W4293252737 cites W2571311335 @default.
• W4293252737 cites W2593053298 @default.
• W4293252737 cites W2597008330 @default.
• W4293252737 cites W2740171683 @default.
• W4293252737 cites W2763605048 @default.
• W4293252737 cites W2768183200 @default.
• W4293252737 cites W2790290999 @default.
• W4293252737 cites W2792960520 @default.
• W4293252737 cites W2793363404 @default.
• W4293252737 cites W2883802901 @default.
• W4293252737 cites W2911502999 @default.
• W4293252737 cites W2914065803 @default.
• W4293252737 cites W2917775077 @default.
• W4293252737 cites W3021561583 @default.
• W4293252737 cites W3173213918 @default.
• W4293252737 cites W4281722258 @default.
• W4293252737 cites W70653800 @default.
• W4293252737 doi "https://doi.org/10.2174/2468187312666220820161123" @default.
• W4293252737 hasPublicationYear "2022" @default.
• W4293252737 type Work @default.
• W4293252737 citedByCount "0" @default.
• W4293252737 crossrefType "journal-article" @default.
• W4293252737 hasAuthorship W4293252737A5004950702 @default.
• W4293252737 hasAuthorship W4293252737A5013250263 @default.
• W4293252737 hasAuthorship W4293252737A5019283465 @default.
• W4293252737 hasAuthorship W4293252737A5031223762 @default.
• W4293252737 hasAuthorship W4293252737A5056099998 @default.
• W4293252737 hasAuthorship W4293252737A5066937344 @default.
• W4293252737 hasConcept C112705442 @default.
• W4293252737 hasConcept C155574463 @default.
• W4293252737 hasConcept C16005928 @default.
• W4293252737 hasConcept C178790620 @default.
• W4293252737 hasConcept C181389837 @default.
• W4293252737 hasConcept C185592680 @default.
• W4293252737 hasConcept C2775839739 @default.
• W4293252737 hasConcept C2777278459 @default.
• W4293252737 hasConcept C2779306117 @default.
• W4293252737 hasConcept C2780564577 @default.
• W4293252737 hasConcept C3019129585 @default.
• W4293252737 hasConcept C43617362 @default.
• W4293252737 hasConcept C55493867 @default.
• W4293252737 hasConcept C58226133 @default.
• W4293252737 hasConcept C71924100 @default.
• W4293252737 hasConcept C98274493 @default.
• W4293252737 hasConceptScore W4293252737C112705442 @default.
• W4293252737 hasConceptScore W4293252737C155574463 @default.
• W4293252737 hasConceptScore W4293252737C16005928 @default.
• W4293252737 hasConceptScore W4293252737C178790620 @default.
• W4293252737 hasConceptScore W4293252737C181389837 @default.
• W4293252737 hasConceptScore W4293252737C185592680 @default.
• W4293252737 hasConceptScore W4293252737C2775839739 @default.
• W4293252737 hasConceptScore W4293252737C2777278459 @default.
• W4293252737 hasConceptScore W4293252737C2779306117 @default.
• W4293252737 hasConceptScore W4293252737C2780564577 @default.
• W4293252737 hasConceptScore W4293252737C3019129585 @default.
• W4293252737 hasConceptScore W4293252737C43617362 @default.
• W4293252737 hasConceptScore W4293252737C55493867 @default.
• W4293252737 hasConceptScore W4293252737C58226133 @default.
• W4293252737 hasConceptScore W4293252737C71924100 @default.
• W4293252737 hasConceptScore W4293252737C98274493 @default.
• W4293252737 hasIssue "2" @default.

• next